GlobalData
Blockchain to help pharma overcome supply problems
Blockchain is set to gain more importance in the healthcare industry by playing a role in a wide range of processes, according to GlobalData. Read more
Pharma industry responds to Brexit meaningful vote
This week (16 January) saw prime minister Theresa May’s Brexit deal firmly defeated in the House of Commons bringing forward the very real possibility of a ‘no deal’ Brexit. Read more
Immuno-oncology to be at forefront of industry in 2019
Immuno-oncology (I-O) and personalised medicine are set to be at the forefront of the pharmaceutical industry in 2019, data shows. Read more
Further development of CAR-T cell therapies in solid tumours will need industry, says GlobalData
GlobalData, a data and analytics company, has reported that further development of chimeric antigen receptor (CAR)-T cell therapies in solid tumours will require collaboration with industry. Read more
New launches into epinephrine injection device market could transform the space, says GlobalData
Data and analytics company, GlobalData, has revealed that it believes new launches into the epinephrine injection device market will have the potential to completely transform the space. Read more
Merck should expect strong sales for two new HIV drugs, says GlobalData
After receiving approval for two HIV drugs, Delstrigo and Pifeltro, Merck should be expecting strong sales but probably unlikely to be at blockbuster levels, according to senior pharma analyst at GlobalData. Read more
The top five tweets: From drones to pharma robots — what ranked top with EPM readers this week?
Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. Read more
Recent approval of Lynparza reflects quickening of Chinese drug approvals, says GlobalData
The recent approval of AstraZeneca/Merck’s Lynparza reflects the accelerating pace of Chinese drug approvals under the country’s new policy regime, according to data and analytics company, GlobalData. Read more
Sanofi Genzyme’s foray into Indian MS market should be met with caution, says GlobalData
Sanofi Genzyme — specialty care global business unit of French pharma company Sanofi — has launched its multiple sclerosis (MS) drug in India, however, according to GlobalData, it should be cautious of fierce generic competition… Read more
Eric Broder Van Dyke / Shutterstock.com
Amazon should make huge strides in healthcare, says GlobalData
According to data and analytics company, GlobalData, Amazon is poised to make huge strides within healthcare as its business model offers easier connectivity between providers and patients and it has a powerful online platform... Read more
Barrier to research may be removed as the public become more accepting of gene editing in animals
According to poll results from Pew Research Center, the American public is accepting of gene editing in animals that could benefit human health, potentially removing a barrier to research, as noted by a pharma analyst at GlobalData. Read more
North Americans are least informed about GDPR, according to GlobalData
Based on its latest report, data and analytics company — GlobalData — has revealed that North Americans are the least informed about the General Data Protection Regulation (GDPR). Read more
Merck & InnoCore collaboration could be a step forward in biologics delivery, says GlobalData
The recent collaboration between Merck and InnoCore Pharmaceuticals for the development of a new drug delivery platform that will improve compliance could be a step forward in the delivery of biologics, according to GlobalData Read more
After profits dip Takeda may find solace in Shire merger, says GlobalData
Following a dip in the first-quarter operating profit announced by Takeda, which is being attributed to the loss of US exclusivity for its blockbuster cancer drug and a lacking pipeline, it may find a saving grace in its recent merger with Shire Read more
The top five tweets: From personalised medicine to HPV vaccine — what did EPM readers click on this week?
Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. Read more
Personalised medicine is an increasing possibility thanks to new algorithms, says GlobalData
According to data and analytics company, GlobalData, personalised medicine is becoming an increasing possibility for patients as a result of newly developed algorithms and the use of big data. Read more
FDA action plan on biosimilars is another positive move towards affordable medicines, says GlobalData
The recently announced ‘Biosimilar Action Plan’ (BAP) from the US Food and Drug Administration (FDA) is another move by the regulatory body to achieve cost-effective pricing, according to an analyst at data and analytics company, GlobalData. Read more
Gaps in Brexit preparedness revealed by EMA survey corresponds with findings of GlobalData
Data and analytics company, GlobalData, has revealed that recent survey findings from the European Medicines Agency (EMA) into Brexit preparedness of the pharma industry support its own conclusions on the matter. Read more
Blockchain will be seen in healthcare supply chain first, according to GlobalData
After learning that pharma giant, Merck, has filed for a US patent for a blockchain-based system, GlobalData has been led to believe that the first applications of blockchain will initially be seen in the healthcare supply chain Read more
The top five tweets: From Brexit to effects of AIS — what captured the attention of EPM readers this week?
Here we count down the top five tweets from @EPM_magazine that have gained the most impressions this week, taken from Twitter analytics. Read more
